April 13, 2022
A patient who successfully challenged Blue Cross Blue Shield of North Carolina's decision to refuse to cover his proton beam cancer treatment asked a federal judge to make the company pick up the tab for $220,000 in attorney fees.
July 30, 2021
A Texas man is seeking a pretrial win in a suit alleging Blue Cross Blue Shield of North Carolina improperly classifies an effective, common and well-regarded cancer treatment as experimental, saying the company can't defend its argument that proton beam radiation therapy isn't medically necessary for prostate cancer patients.